Consumer Protection Against the Use of Syrup Drugs Containing Ethylene Glycol and Diethylene Glycol Exceeding the Safe Threshold
Abstract
Drugs are supposed to cure, but when they contain substances exceeding
safe limits, they do not cure but are potentially harmful. Based on case in 2022
found that in the market syrup medicines for children that contain EG and DEG
exceeding the safe threshold. This research aims to know the consumer protection
against the use of syrup drugs containing ethylene glycol and diethylene glycol
exceeding the safe threshold and the responsibility of businesses and National
Agency for Drug and Food Control for such a drug. This research is conducted by
a normative method by examining library or secondary materials and using Statute
Approach, Conceptual Approach, and Case Approach. This study reveals that renal
failure due to the use of EG and DEG syrup medications may be caused by the
ineffective monitoring when issuing drug distribution permits and also caused by
the companies who were dishonest in determining medicine doses. As a form of
responsibility, the company should pay compensation in the form of medical
treatment or in line with the rules and regulations that apply. The National Agency
for Drug and Food Control should regularly conduct risk-based testing and random
sampling as a form of accountability.
Collections
- Law [2335]